# Monte Rosa Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:4c73d323-73f1-488a-bdd2-da194d006937 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/monte-rosa-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 38 | | Claims under review | 1 | | Evidence records | 12 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-19T14:44:00.936526+00:00 | | Last reviewed | 2026-10-19T14:44:00.936526+00:00 | ## Identity - Legal name: Monte Rosa Therapeutics, Inc. - Display name: Monte Rosa Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-19T23:41:06.470459+00:00 | | Completeness | 0.409 | | Record Quality | 0.839 | | Directors | 12 | | Committees | 4 | | Governance events | 15 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Ali Behbahani: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:6 - Anthony Manning, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:8 - Chandra P. Leo: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: AUDIT COMMITTEE (member); compensation committee (member); Nomination and Corporate Governance Committee (member). claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:9 - Christine Siu: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. Committees: AUDIT COMMITTEE (chair); compensation committee (chair); Nomination and Corporate Governance Committee (chair). claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:10 - Eric Hughes, M.D., Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:12 - Kimberly L. Blackwell: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:14 - Markus Warmuth, M.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:16 - Andrew Schiff: Non-Executive Chair of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:5 - Anthony Manning: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:7 - Eric Hughes: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:11 - Jan Skvarka: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:13 - Markus Warmuth: Chief Executive Officer, President and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Director (member). claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:15 ## Committees - AUDIT COMMITTEE (audit). Chair: Christine Siu. Members: Christine Siu (chair, current); Chandra P. Leo (member, current). committee_id=alpha:committee:monte-rosa-therapeutics-inc:audit-committee - compensation committee (compensation). Chair: Christine Siu. Members: Christine Siu (chair, current); Chandra P. Leo (member, current). committee_id=alpha:committee:monte-rosa-therapeutics-inc:compensation-committee - Nomination and Corporate Governance Committee (nominating_governance). Chair: Christine Siu. Members: Christine Siu (chair, current); Chandra P. Leo (member, current). committee_id=alpha:committee:monte-rosa-therapeutics-inc:nomination-and-corporate-governance-committee - President and Director (other). Chair: NOT_PUBLISHED. Members: Markus Warmuth (member, unknown). committee_id=alpha:committee:monte-rosa-therapeutics-inc:president-and-director ## Executive leadership - Anthony Manning, Ph.D.: Named Executive Officer / Director Nominee. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:17 - Champoux: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:18 - Eric Hughes, M.D., Ph.D.: Named Executive Officer. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:19 - Filip Janku, M.D., Ph.D.: Named Executive Officer. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:21 - Jan Skvarka, Ph.D., MBA: Named Executive Officer. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:22 - Markus Warmuth, M.D.: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:25 - Philip Nickson, J.D., Ph.D.: Chief Business and Legal Officer. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:27 - Townson: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:29 - Filip Janku: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:20 - Jennifer Champoux: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:23 - Markus Warmuth: Chief Executive Officer and President [CEO]. Status: unknown. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:24 - Philip Nickson: Chief Business and Legal Officer. Status: unknown. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:26 - Sharon Townson: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:28 ## Governance events - EXECUTIVE_APPOINTED: Anthony Manning, Ph.D. executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:13h8u61jvj9hi - EXECUTIVE_APPOINTED: Champoux executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:ghxl1hbnubi1 - EXECUTIVE_APPOINTED: Eric Hughes, M.D., Ph.D. executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:o4m0yf1pil89x - EXECUTIVE_APPOINTED: Filip Janku, M.D., Ph.D. executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1i65gszil47ep - EXECUTIVE_APPOINTED: Jan Skvarka, Ph.D., MBA executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1i1uav6ix7edc - CEO_CHANGED: Markus Warmuth, M.D. executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:ye0kbvmm2spf - EXECUTIVE_APPOINTED: Philip Nickson, J.D., Ph.D. executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:4yph9q122r6hm - EXECUTIVE_APPOINTED: Townson executive of Monte Rosa Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:16jtbwr1wbscgn - DIRECTOR_APPOINTED: Eric Hughes, M.D., Ph.D. seat on Monte Rosa Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:wr2bi9du5gtv - DIRECTOR_APPOINTED: Anthony Manning, Ph.D. seat on Monte Rosa Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1fjhhs71s0y8uz - DIRECTOR_APPOINTED: Ali Behbahani seat on Monte Rosa Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:1da8a6e14j9xs6 - DIRECTOR_APPOINTED: Chandra P. Leo seat on Monte Rosa Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:5ver4zbklo45 - DIRECTOR_APPOINTED: Christine Siu seat on Monte Rosa Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:zybqlvp79syt - DIRECTOR_APPOINTED: Kimberly L. Blackwell seat on Monte Rosa Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:urlfh31uqeqr5 - DIRECTOR_APPOINTED: Markus Warmuth, M.D. seat on Monte Rosa Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-19T14:44:00.936526+00:00. event_id=alpha:event:transition:ewlv514bdpir ## Scoped resources - `alpha://company/monte-rosa-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record - `alpha://company/monte-rosa-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=identity - `alpha://company/monte-rosa-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/monte-rosa-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=board - `alpha://company/monte-rosa-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=committees - `alpha://company/monte-rosa-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=leadership - `alpha://company/monte-rosa-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=ownership - `alpha://company/monte-rosa-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=financials - `alpha://company/monte-rosa-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/monte-rosa-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=compensation - `alpha://company/monte-rosa-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=governance - `alpha://company/monte-rosa-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/monte-rosa-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=audit - `alpha://company/monte-rosa-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=legal - `alpha://company/monte-rosa-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=risk - `alpha://company/monte-rosa-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=cyber - `alpha://company/monte-rosa-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/monte-rosa-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=agents - `alpha://company/monte-rosa-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/monte-rosa-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=events - `alpha://company/monte-rosa-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=relationships - `alpha://company/monte-rosa-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=assessments - `alpha://company/monte-rosa-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:31: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:christine-siu-glue","name":"Christine Siu"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:32: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE","category":"audit","role":"member","person":{"alpha_id":"alpha:person:chandra-p-leo-glue","name":"Chandra P. Leo"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:34: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:christine-siu-glue","name":"Christine Siu"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:35: `{"kind":"committee_appointment","original_name":"compensation committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:chandra-p-leo-glue","name":"Chandra P. Leo"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:37: `{"kind":"committee_appointment","original_name":"Nomination and Corporate Governance Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:christine-siu-glue","name":"Christine Siu"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Nomination and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:chandra-p-leo-glue","name":"Chandra P. Leo"},"source_id":"governance_people_committees"}` ## Leadership - Andrew Schiff: Non-Executive Chair of the Board. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Ali Behbahani: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04. - Anthony Manning: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Anthony Manning, Ph.D.: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04. - Chandra P. Leo: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04. - Christine Siu: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04. - Eric Hughes: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Eric Hughes, M.D., Ph.D.: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:12. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04. - Jan Skvarka: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Kimberly L. Blackwell: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:14. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04. - Markus Warmuth: Chief Executive Officer, President and Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Markus Warmuth, M.D.: Director. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:16. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04. - Anthony Manning, Ph.D.: Named Executive Officer / Director Nominee. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:17. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:06e24493a408f52eba4eb2c1e8cfc226a08d2a96979cff7f05cde5deee51c097. - Champoux: Chief Operating Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:18. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:02e07c14237bd1aa490ac68c4e0d5f06766b8563398e8b2a99c03087b297d468. - Eric Hughes, M.D., Ph.D.: Named Executive Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:19. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2a2781759a8c68a7e0595194a2b1abc193082d87c28b481a299cd8d8c660b60e. - Filip Janku: Chief Medical Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Filip Janku, M.D., Ph.D.: Named Executive Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:21. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6232eb31d79cc0da779a82dc779aab9c41d56571ee8216e7e768db261fcb664. - Jan Skvarka, Ph.D., MBA: Named Executive Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:22. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:252d5b6fbc9e2bb680123f61c6a98602fbe6f8b0ae3177d9e09bb586a063429f. - Jennifer Champoux: Chief Operating Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Markus Warmuth: Chief Executive Officer and President. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Markus Warmuth, M.D.: Chief Executive Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:25. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6e16da2302092ed535520d429a1ac4b0b9659c6dda4a99654d2f01206338b1cd. - Philip Nickson: Chief Business and Legal Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Philip Nickson, J.D., Ph.D.: Chief Business and Legal Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:27. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b5916301d4ea305b4305f3d8e7a745a9f02dfa74a68eb3b02184a6a9500a4cda. - Sharon Townson: Chief Scientific Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd. - Townson: Chief Scientific Officer. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:leadership_role:29. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:88033b8cf1c69a4a847c72733408ecb2ab4d57b1604d6d9070810d500547316a. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - AUDIT COMMITTEE: Chair Christine Siu; Members Christine Siu (Chair); Chandra P. Leo. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_record:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. - compensation committee: Chair Christine Siu; Members Christine Siu (Chair); Chandra P. Leo. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_record:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. - Nomination and Corporate Governance Committee: Chair Christine Siu; Members Christine Siu (Chair); Chandra P. Leo. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_record:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Monte Rosa Therapeutics, Inc.. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14cc4193b06c36266ccd5805d1fe9b3083e0fc681e68d708152f0548d83b21c2. ## Entity Status - Public listing published. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14cc4193b06c36266ccd5805d1fe9b3083e0fc681e68d708152f0548d83b21c2. ## Published Fact - US. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14cc4193b06c36266ccd5805d1fe9b3083e0fc681e68d708152f0548d83b21c2. ## Committee Appointment - Christine Siu: chair, AUDIT COMMITTEE. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. - Chandra P. Leo: member, AUDIT COMMITTEE. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. - Christine Siu: chair, compensation committee. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. - Chandra P. Leo: member, compensation committee. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. - Christine Siu: chair, Nomination and Corporate Governance Committee. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. - Chandra P. Leo: member, Nomination and Corporate Governance Committee. Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e. ## Security Listing - GLUE (NASDAQ). Claim: alpha:claim:company:4c73d323-73f1-488a-bdd2-da194d006937:security_listing:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:14cc4193b06c36266ccd5805d1fe9b3083e0fc681e68d708152f0548d83b21c2. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:14cc4193b06c36266ccd5805d1fe9b3083e0fc681e68d708152f0548d83b21c2: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc). - alpha:projection-evidence:document:f6c021b82d17c3fa96e4420830f2f7c416f68bc7d7248fbbce52338b273e4bbd: [SEC DEF 14A 0001193125-26-191439](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:fed6e05dd299641cb36f0eea4134a634a076cc164d9564b2b6a6922ae3849d04: [DEF 14A glue-20260429.htm](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:06e24493a408f52eba4eb2c1e8cfc226a08d2a96979cff7f05cde5deee51c097: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:02e07c14237bd1aa490ac68c4e0d5f06766b8563398e8b2a99c03087b297d468: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:2a2781759a8c68a7e0595194a2b1abc193082d87c28b481a299cd8d8c660b60e: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:f6232eb31d79cc0da779a82dc779aab9c41d56571ee8216e7e768db261fcb664: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:252d5b6fbc9e2bb680123f61c6a98602fbe6f8b0ae3177d9e09bb586a063429f: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:6e16da2302092ed535520d429a1ac4b0b9659c6dda4a99654d2f01206338b1cd: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:b5916301d4ea305b4305f3d8e7a745a9f02dfa74a68eb3b02184a6a9500a4cda: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:document:88033b8cf1c69a4a847c72733408ecb2ab4d57b1604d6d9070810d500547316a: [GLUE DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). - alpha:projection-evidence:612942a7e0f4d6f699496fa5ded8eec40a4ba0ccc352ef5ad25f9c4bb71e6b2e: [AUDIT COMMITTEE](https://www.sec.gov/Archives/edgar/data/1826457/000119312526191439/glue-20260429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/monte-rosa-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/monte-rosa-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/monte-rosa-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/monte-rosa-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-19T23:41:06.25629+00:00; recorded 2026-10-19T23:41:06.25629+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.